Healthcare provider profile · identity verified

Michelle L Lightner, PAC

Physician Assistant · FAYETTEVILLE, NC · NPI 1083603120

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	334	101
Rosuvastatin Calcium	Rosuvastatin Calcium	283	87
Gabapentin	Gabapentin	280	75
Omeprazole	Omeprazole	268	86
Lisinopril	Lisinopril	260	73
Losartan Potassium	Losartan Potassium	247	76
Alprazolam	Alprazolam	235	37
Hydrochlorothiazide	Hydrochlorothiazide	200	67
Atorvastatin Calcium	Atorvastatin Calcium	177	60
Simvastatin	Simvastatin	160	47
Levothyroxine Sodium	Levothyroxine Sodium	157	50
Zolpidem Tartrate	Zolpidem Tartrate	153	21
Albuterol Sulfate Hfa	Albuterol Sulfate	136	38
Alendronate Sodium	Alendronate Sodium	128	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	126	19
Ozempic	Semaglutide	119	18
Metoprolol Succinate	Metoprolol Succinate	118	29
Potassium Chloride	Potassium Chloride	116	35
Baclofen	Baclofen	114	31
Meloxicam	Meloxicam	113	41
Glipizide Er	Glipizide	110	27
Ezetimibe	Ezetimibe	108	29
Pantoprazole Sodium	Pantoprazole Sodium	95	35
Tramadol Hcl	Tramadol Hcl	93	24
Tizanidine Hcl	Tizanidine Hcl	87	14
Furosemide	Furosemide	85	36
Ibuprofen	Ibuprofen	83	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	79	72
Bupropion Xl	Bupropion Hcl	78	23
Metformin Hcl Er	Metformin Hcl	76	25
Sertraline Hcl	Sertraline Hcl	76	22
Escitalopram Oxalate	Escitalopram Oxalate	72	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	14
Fluticasone Propionate	Fluticasone Propionate	71	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	18
Duloxetine Hcl	Duloxetine Hcl	68	13
Metformin Hcl	Metformin Hcl	68	21
Eliquis	Apixaban	63	15
Trazodone Hcl	Trazodone Hcl	61	13
Pravastatin Sodium	Pravastatin Sodium	60	19
Atenolol	Atenolol	56	19
Prednisone	Prednisone	56	42
Tamsulosin Hcl	Tamsulosin Hcl	54	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	18
Clopidogrel	Clopidogrel Bisulfate	48	16
Chlorthalidone	Chlorthalidone	46	13
Montelukast Sodium	Montelukast Sodium	45	15
Clonazepam	Clonazepam	44	suppressed
Carvedilol	Carvedilol	42	16
Nifedipine Er	Nifedipine	42	12
Hydroxyzine Hcl	Hydroxyzine Hcl	39	12
Celecoxib	Celecoxib	37	suppressed
Clonidine Hcl	Clonidine Hcl	36	11
Metoprolol Tartrate	Metoprolol Tartrate	36	11
Oxybutynin Chloride Er	Oxybutynin Chloride	34	11
Allopurinol	Allopurinol	33	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	11
Nystatin	Nystatin	30	14
Mounjaro	Tirzepatide	29	suppressed
Azithromycin	Azithromycin	28	24
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Topiramate	Topiramate	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	11
Buspirone Hcl	Buspirone Hcl	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Vitamin D2	Ergocalciferol (Vitamin D2)	24	11
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Pregabalin	Pregabalin	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Naproxen	Naproxen	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Fluconazole	Fluconazole	19	16
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Temazepam	Temazepam	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Famotidine	Famotidine	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Estradiol	Estradiol	16	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Valsartan	Valsartan	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error